Cargando…
Carbonic anhydrase activation profile of indole-based derivatives
Carbonic Anhydrase Activators (CAAs) could represent a novel approach for the treatment of Alzheimer’s disease, ageing, and other conditions that require remedial achievement of spatial learning and memory therapy. Within a research project aimed at developing novel CAAs selective for certain isofor...
Autores principales: | Barresi, Elisabetta, Ravichandran, Rahul, Germelli, Lorenzo, Angeli, Andrea, Baglini, Emma, Salerno, Silvia, Marini, Anna Maria, Costa, Barbara, Da Pozzo, Eleonora, Martini, Claudia, Da Settimo, Federico, Supuran, Claudiu, Cosconati, Sandro, Taliani, Sabrina |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Taylor & Francis
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8344252/ https://www.ncbi.nlm.nih.gov/pubmed/34340630 http://dx.doi.org/10.1080/14756366.2021.1959573 |
Ejemplares similares
-
Tetrahydroquinazole-based secondary sulphonamides as carbonic anhydrase inhibitors: synthesis, biological evaluation against isoforms I, II, IV, and IX, and computational studies
por: Baglini, Emma, et al.
Publicado: (2021) -
Carbonic Anhydrase Activators for Neurodegeneration: An Overview
por: Poggetti, Valeria, et al.
Publicado: (2022) -
Target-Based Anticancer Indole Derivatives for the Development of Anti-Glioblastoma Agents
por: Salerno, Silvia, et al.
Publicado: (2023) -
Indol-3-ylglyoxylamide as Privileged Scaffold in Medicinal Chemistry
por: Barresi, Elisabetta, et al.
Publicado: (2023) -
Novel 2-substituted-benzimidazole-6-sulfonamides as carbonic anhydrase
inhibitors: synthesis, biological evaluation against isoforms I, II, IX and XII and
molecular docking studies
por: Milite, Ciro, et al.
Publicado: (2019)